Cynthia Smith
CIK 1609480 · Chief Commercial Officer · last filed 2026-06-25
Cynthia Smith is a Chief Commercial Officer who has filed 47 SEC Form 4 insider transactions across 7 companies since 2014. The most recent filing, for SPRO, was dated Jun 25, 2026. Across all open-market trades the lifetime net is −$2.5K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $899.4K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$899.4K
7
47
-$2.5K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SPRO | Director | 85,000 | $1.20 | $101.6K | $0 | 10 | 2026-06-25 |
| AGIO | Director | 15,230 | $35.99 | $548.1K | $0 | 9 | 2026-06-23 |
| AKBA | Director | 196,633 | $1.27 | $249.7K | -$2.5K | 10 | 2026-06-22 |
| TARA | Director | — | $3.94 | — | $0 | 7 | 2026-06-16 |
| TVRD | Director | — | $2.44 | — | $0 | 2 | 2026-06-11 |
| Dicerna Pharmaceuticals Inc (DRNA) Delisted | Director | 0 | $38.22 | $0 | $0 | 5 | 2021-12-29 |
| ZS Pharma, Inc. (ZSPH) Delisted | Chief Commercial Officer | 9,155 | — | — | $0 | 3 | 2015-12-10 |
Recent Filings
47 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-25 | SPRO | Grant (A) | +10,000 | $0 | EDGAR |
| 2026-06-23 | AGIO | Mixed | +2,816 | $0 | EDGAR |
| 2026-06-22 | AKBA | Grant (A) | +35,700 | $0 | EDGAR |
| 2026-06-16 | TARA | Grant (A) | — | $0 | EDGAR |
| 2026-06-11 | TVRD | Grant (A) | — | $0 | EDGAR |
| 2025-08-13 | AGIO | Exer (M) | +2,302 | $0 | EDGAR |
| 2025-06-23 | AGIO | Mixed | +2,120 | $0 | EDGAR |
| 2025-06-16 | SPRO | Grant (A) | +20,000 | $0 | EDGAR |
| 2025-06-13 | TARA | Grant (A) | — | $0 | EDGAR |
| 2025-06-11 | AKBA | Grant (A) | +35,700 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.